Cooper adds that scientists need to better integrate data to provide a more holistic picture of biodiversity trends. "We need to develop a monitoring system," he told Nature.
The Biodiversity Observation Network of the Group on Earth Observations offers such a system for 'joining the dots' of global biodiversity knowledge. Launched in 2008, the network aims to be a one-stop shop for information on biodiversity. It will release indicators, generate maps of priority areas, provide conservation plans and report on trends in uses of biological resources.
Chairman Bob Scholes, of South Africa's Council for Scientific and Industrial Research, says the network will start producing a "strong element" of this bigger picture in two to three years' time.
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Hazy goals hold up conservation involve commercial production at manufacturing facilities in Russia. They include the Novosibirsk-based company Sun Innovations, which produces nano-ink for printers, and Rybinsk-based Saturn, which makes nano-structured coatings for use in aircraft.
Russia is also keen to attract international partners, which has proved difficult. Only two projects involving foreign partners have been approved so far, including a 1.1-billion-rouble joint venture with the German firm VI Systems in Berlin. The company, which develops laser-based components for ultra-high-speed computers, networks and interconnects, will start production in 2011 at a newly built facility in St Petersburg. "It's a perfect match for us, " says company founder Nikolay Ledentsov, a physicist formerly with the Ioffe Physical Technical Institute in St Petersburg. VI Systems currently manufactures its devices in Taiwan and elsewhere. "In the future we can safely produce in Russia, itself an emerging market for electronics, and share profits, " he says.
Rusnano is also participating in joint infrastructure projects with firms such as RusChemBio, a Moscow-based 24-hour delivery service that supplies imported compounds and reagents required for clinical diagnostics, chemistry and drug development. Several drug companies, including Roche and Aventis, said at the forum that they will discuss setting up joint ventures in drug development with Rusnano.
Russia's push into nanotech is part of its larger effort to strengthen basic science and education. The Kurchatov Institute, Russia's premier centre for nuclear physics, last year received more than 5.9 billion roubles from the government to set up a new centre for nano-, bio-, info-and cognitive sciences, including a state-of-the-art genome-sequencing facility, an upgraded synchrotron radiation machine and a new data-processing centre. And concrete plans exist for a national research centre for nanotechnology that includes the Kurchatov and several research centres run by the Russian Academy of Sciences.
But experts warn of exaggerated hopes. "Russia is throwing a lot of money and brain power at nanotechnology, " says Ian Miles, an expert on technological innovation at the University of Manchester, UK. "But favourable conditions, from more favourable starting points, are being created everywhere. It's not going to be easy. "
